A single-blind, randomized, controlled trial of the effect of kestose intake during pregnancy and lactation women on mother and infant microbiome - Fukushima study 2

akano Taiji0 个研究点目标入组 220 人开始时间: 2024年1月25日最近更新: 2024年4月23日

适应症

试验速览

暂无简介。

•pregnant woman
•1) Pregnant women who are scheduled to continue their prenatal checkups and have their delivery and postpartum checkups at the facility where the study is conducted
•2) Pregnant women who are between 20 and 45 years of age at the time of consent
•3) Pregnant women who are less than 26 weeks pregnant at the time of consent
•4) Pregnant women who have received a full explanation of their participation in this study and who have given written consent of their own free will based on full understanding
•1) A newborn whose surrogate has been fully informed of the study, fully understands the study, and has given his/her free and voluntary written consent to participate in the study

•pregnant woman
•1) Pregnant women with fetal morphological abnormalities, pregnant women with twins or more
•2) pregnant women with a history of serious illness
•3) Pregnant women who used antibiotics between 20 and 26 weeks of gestation
•4) Pregnant women who will be treated with antibiotics at childbirth
•5) Pregnant women who are allergic to the test food
•6) Pregnant women who will intake of other oligosaccharides or prebiotics during this study period
•7) Pregnant women who will participate other study (e.g. other foods, drugs or skin care products) during this study period
•8) Pregnant women who cannot understand Japanese
•9) Pregnant women who are judged to be ineligible by the principal investigator or subinvestigator
•1) Newborns with serious diseases

发起方

akano Taiji